Abstract
Purpose: To quantitatively evaluate two Methods: portal dosimetry and MatriXX placed in a dedicated holder, for clinical VMAT patient specific QA using gamma analysis. Methods: 21 prostate VMAT double‐arc plans were generated in Eclipse. We used portal dosimetry and MatriXX to conduct plan verifications. Portal dosimetry, including the absolute dose mode, was commissioned according to Varians guide. The MatriXX was commissioned as per vendor manual. In our study, Matrixx was inserted in a dedicated holder that was mounted on a linac treatment head with 5.0cm effective depth from the surface to the detector plane. In this geometry, the MatriXX detector plane is always facing the source perpendicularly. Thus the angular corrections for MatriXX detectors were not required. Gamma index was calculated using appropriate values of dose difference and distance‐to‐agreement. The threshold value, used for excluding low dose regions, was set to 5%. In portal dosimetry, calculated dose and measured dose were auto‐aligned and gamma index was obtained in the absolute dose mode. Portal dosimetry system was calibrated weekly or as needed to ensure its optimal working conditions. Results: In the MatriXX measurement, the Bland Altman plot was used to show that, with 95% confidence level, the measured Dmax agreed with the calculated Dmax. Then the dose distributions measured from MatriXX were normalized to Dmax and IBA so±ftware was used for gamma analysis. For gamma index calculated with 3%/3mm, both portal dosimetry (98.6%±1.1%) and MatriXX (97.0%±1.1%) exhibit similar passing rates, with portal doismetry demonstrating slightly higher passing rates than MatriXX. Conclusion: This work indicates that for VMAT patient specific QA, a well calibrated portal dosimetry system can be equivalent to or better than the MatriXX system. Future endeavors may extend to the analysis of VMAT plans for other sites and exploration of the method using the MatriXX inserted in a MultiCube phantom.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.